Patients receiving live/attenuated vaccinations within  weeks prior to registration are not eligible
Any vaccinations four weeks prior to the first vaccination cycle or live vaccines at any time during the study
Live attenuated vaccinations  days prior to treatment
Active and inactive vaccinations within  weeks of the first dose of avelumab and while on trial is prohibited
Live attenuated vaccinations within  days prior to treatment
Live attenuated vaccinations  days prior to treatment
Use of live vaccines against infectious disease (e.g. varicella) within  days of initiation of study therapy; killed vaccinations (e.g. influenza) are allowed at any appropriate time before and during the study
Vaccinations initiated between  weeks and  months from completion of SoC multi-modality cancer care
Routine vaccinations, including seasonal influenza, should be given at least  weeks prior to study treatment; vaccines are not prohibited on study, but must be given at least  weeks after cycle  and not within  days of treatment
RANDOMIZED PHASE II (ARMS K AND L): Routine vaccinations, including seasonal influenza, should be given at least  weeks prior to study treatment; vaccines are not prohibited on study, but must be given at least  weeks after cycle  and not within  days of treatment
Vaccinations against encapsulated bacterial pathogens (Neisseria meningitis, including serogroup B meningococcus, Haemophilus influenzae, and Streptococcus pneumoniae) within  years of enrollment
Vaccinations other than those given as part of this research study (with the exception of influenza vaccine) are prohibited throughout the duration of study participation\r\n* NOTE: Influenza vaccination (inactivated) is permitted during the flu season; the preferred time is  to  days after CDX- administration
Patients taking live vaccines including yellow fever vaccinations
Unwilling to avoid vaccinations with live vaccine and concomitant use of attenuated live vaccines
Live attenuated vaccinations  days prior to treatment
It is encouraged that standard of care vaccinations are not offered during the  weeks preceding plasma HIV- RNA measurements, and that standard of care vaccinations are not administered at the same time as the study vaccine; routine vaccinations other than influenza vaccine that are administered after enrollment in the study should be given  month before or after HPV vaccination (or any visit where antibody titers are measured) during the study period. Influenza vaccination may be given within  week before or after HPV vaccination visits
Has taken any live vaccinations within  days before study drug administration except for the influenza vaccine.